Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Merlini

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
Il Giornale Di Chirurgia|June 20, 2012
Severity in biliary peritonitisL Izzo, R Gabriele, M Conte, et al.
International Journal of Oncology|May 12, 2011
A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myelomaA Riccardi, G Ucci, S Brugnatelli, et al.
Protein Science : a Publication of the Protein Society|June 13, 2000
Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formationG Esposito, R Michelutti, G Verdone, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 16, 2011
The diflunisal trial: update on study drug tolerance and disease progressionJ L Berk, P J Dyck, L Obici, et al.
Haematologica|March 1, 1996
Familial AL-amyloidosis in three Italian siblingsA Miliani, F Bergesio, M Salvadori, et al.
Leukemia|April 6, 2012
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosisR L Comenzo, D Reece, G Palladini, et al.
Il Giornale Di Chirurgia|June 20, 2012
Insulin-like growth factor-I (IGF-1), IGF-binding protein-3 (IGFBP-3) and mammographic featuresL Izzo, M L Meggiorini, I Nofroni, et al.
Journal of Hematology & Oncology|January 18, 2018
Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert PanelJ Caers, B Paiva, E Zamagni, et al.
European Journal of Neurology|April 29, 2020
Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trialT H Brannagan, A K Wang, T Coelho, et al.
QJM : Monthly Journal of the Association of Physicians|July 15, 2011
Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effectsS W Dubrey, D E Reece, V Sanchorawala, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Il Giornale Di Chirurgia|June 20, 2012
Severity in biliary peritonitisL Izzo, R Gabriele, M Conte, et al.
International Journal of Oncology|May 12, 2011
A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myelomaA Riccardi, G Ucci, S Brugnatelli, et al.
Protein Science : a Publication of the Protein Society|June 13, 2000
Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formationG Esposito, R Michelutti, G Verdone, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 16, 2011
The diflunisal trial: update on study drug tolerance and disease progressionJ L Berk, P J Dyck, L Obici, et al.
Haematologica|March 1, 1996
Familial AL-amyloidosis in three Italian siblingsA Miliani, F Bergesio, M Salvadori, et al.
Leukemia|April 6, 2012
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosisR L Comenzo, D Reece, G Palladini, et al.
Il Giornale Di Chirurgia|June 20, 2012
Insulin-like growth factor-I (IGF-1), IGF-binding protein-3 (IGFBP-3) and mammographic featuresL Izzo, M L Meggiorini, I Nofroni, et al.
Journal of Hematology & Oncology|January 18, 2018
Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert PanelJ Caers, B Paiva, E Zamagni, et al.
European Journal of Neurology|April 29, 2020
Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trialT H Brannagan, A K Wang, T Coelho, et al.
QJM : Monthly Journal of the Association of Physicians|July 15, 2011
Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effectsS W Dubrey, D E Reece, V Sanchorawala, et al.
Pageof 16